Artigo de periodico

Residual macrovascular risk in 2013: what have we learned? (2014)

• Authors:
  • Fruchart, Jean-Charles
  • Davignon, Jean
  • Hermans, Michel P.
  • Al-Rubeaan, Khalid
  • Amarenco, Pierre
  • Assmann, Gerd
  • Barter, Philip
  • Betteridge, John
  • Bruckert, Eric
  • Cuevas, Ada
  • Farnier, Michel
  • Ferrannini, Ele
  • Fioretto, Paola
  • Genest, Jacques
  • Ginsberg, Henry N.
  • Gotto, Antonio M.
  • Hu, Dayi
  • Kadowaki, Takashi
  • Kodama, Tatsuhiko
  • Krempf, Michel
  • Matsuzawa, Yuji
  • Núñez-Cortés, Jesús
  • Monfil, Carlos
  • Ogawa, Hisao
  • Plutzky, Jorge
  • Rader, Daniel J.
  • Sadikot, Shaukat
  • Santos, Raul D.
  • Shlyakhto, Evgeny
  • Sritara, Piyamitr
  • Sy, Rody
  • Tall, Alan
  • Tan, Chee Eng
  • Tokgözoğlu, Lale
  • Toth, Peter P.
  • Valensi, Paul
  • Wanner, Christoph
  • Zambon, Alberto
  • Zhu, Junren
  • Zimmet, Paul
• USP affiliated authors: SANTOS FILHO, RAUL DIAS DOS - FM
• Unidades: FM
• DOI: 10.1186/1475-2840-13-26
• Subjects: FATORES DE RISCO; SISTEMA CARDIOVASCULAR (ANORMALIDADES); DISLIPIDEMIAS; DIABETES MELLITUS
• Language: Inglês
• Imprenta:
  • Place of publication: London
  • Date published: 2014
• Source:
  • Título do periódico: Cardiovascular Diabetology
  • ISSN: 1475-2840
  • Volume/Número/Paginação/Ano: v. 13, n. 26, 17 p. (on-line), 2014

Informações sobre o DOI: 10.1186/1475-2840-13-26 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: gold
• Licença: cc-by

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  FRUCHART, Jean-Charles; DAVIGNON, Jean; HERMANS, Michel P.; et al. Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, London, v. 13, n. 26, p. 17 (on-line), 2014. Disponível em: < http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf > DOI: 10.1186/1475-2840-13-26.

• APA

  Fruchart, J. -C., Davignon, J., Hermans, M. P., Al-Rubeaan, K., Amarenco, P., Assmann, G., et al. (2014). Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, 13( 26), 17 (on-line). doi:10.1186/1475-2840-13-26

• NLM

  Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf

• Vancouver

  Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
• Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia
• Case report [Editorial]: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
• Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
• Capítulo complementar: lipoproteína de baixa densidade (LDL) e prevenção da doença cardiovascular
• Angiotensinogen gene polymorphism and HDL2 are linked to coronary artery calcification in individuals with family history of early coronary disease
• Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
• Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients?: a post-hoc analysis
• Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
• An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary